Literature DB >> 12060388

Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.

Olivier Dereure1, Edi Levi, Eric C Vonderheid, Marshall E Kadin.   

Abstract

Mycosis fungoides (MF) is the most frequent manifestation of cutaneous T cell lymphoma but its cause and pathophysiology remain unclear. Because progression of lesions is characteristically slow, we hypothesized that mycosis fungoides originates from an accumulation of lymphocytes due to defective apoptosis of skin homing T lymphocytes. In this study, we investigate possible alterations of three molecules regulating apoptosis, i.e., Fas antigen, Bax, and p53, at the genomic level in skin lesions from 44 patients with MF, as Fas mediates one of two major pathways for apoptosis of activated T cells. Fas mutations were found in six patients using a polymerase chain reaction and single-strand conformational polymorphism method followed by cloning and sequencing of abnormal polymerase chain reaction products. The mutations predict for defective transmission of the death signal in three cases. Immunohistochemistry demonstrated the lack of Fas protein expression on dermal lymphocytes in one case with Fas gene mutation predicting for a truncated death domain, whereas Fas protein was expressed by dermal lymphocytes in the other investigated cases. By contrast, no mutations of Bax or p53 were found, whereas immunohistochemistry demonstrated increased p53 expression in the nucleus of basal keratinocytes above the neoplastic infiltrate in some MF cases. These results support the hypothesis that Fas defects may play a role in the pathogenesis of MF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060388     DOI: 10.1046/j.1523-1747.2002.01794.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  20 in total

1.  Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL).

Authors:  Jianqiang Wu; Jawed Siddiqui; Minakshi Nihal; Eric C Vonderheid; Gary S Wood
Journal:  Arch Biochem Biophys       Date:  2010-10-29       Impact factor: 4.013

2.  Diverse cutaneous manifestations associated with a single disease.

Authors:  Jennifer Clay Cather; Estil A Vance; M Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

3.  Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).

Authors:  Ulrik Ralfkiaer; Peter H Hagedorn; Nannie Bangsgaard; Marianne B Løvendorf; Charlotte B Ahler; Lars Svensson; Katharina L Kopp; Marie T Vennegaard; Britt Lauenborg; John R Zibert; Thorbjørn Krejsgaard; Charlotte M Bonefeld; Rolf Søkilde; Lise M Gjerdrum; Tord Labuda; Anne-Merete Mathiesen; Kirsten Grønbæk; Mariusz A Wasik; Malgorzata Sokolowska-Wojdylo; Catherine Queille-Roussel; Robert Gniadecki; Elisabeth Ralfkiaer; Carsten Geisler; Thomas Litman; Anders Woetmann; Christian Glue; Mads A Røpke; Lone Skov; Niels Odum
Journal:  Blood       Date:  2011-08-24       Impact factor: 22.113

4.  Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR.

Authors:  Duncan Murray; Jack Luke McMurray; Suzy Eldershaw; Hayden Pearce; Nathaniel Davies; Julia J Scarisbrick; Paul Moss
Journal:  Blood Adv       Date:  2019-02-26

Review 5.  CD95-mediated cell signaling in cancer: mutations and post-translational modulations.

Authors:  Sébastien Tauzin; Laure Debure; Jean-François Moreau; Patrick Legembre
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

Review 6.  Immunopathogenesis and therapy of cutaneous T cell lymphoma.

Authors:  Ellen J Kim; Stephen Hess; Stephen K Richardson; Sara Newton; Louise C Showe; Bernice M Benoit; Ravi Ubriani; Carmela C Vittorio; Jacqueline M Junkins-Hopkins; Maria Wysocka; Alain H Rook
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

7.  Altered microRNA expression in folliculotropic and transformed mycosis fungoides.

Authors:  Dóra Marosvári; Vanda Téglási; Irén Csala; Márta Marschalkó; Csaba Bödör; Botond Timár; Judit Csomor; Judit Hársing; Lilla Reiniger
Journal:  Pathol Oncol Res       Date:  2015-02-20       Impact factor: 3.201

8.  Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the antiapoptotic protein Ku70.

Authors:  K Ferenczi; J Ohtola; P Aubert; M Kessler; H Sugiyama; A K Somani; A C Gilliam; J Z Chen; I Yeh; S Matsuyama; T S McCormick; K D Cooper
Journal:  Br J Dermatol       Date:  2010-09       Impact factor: 9.302

Review 9.  Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.

Authors:  William E Damsky; Jaehyuk Choi
Journal:  Curr Treat Options Oncol       Date:  2016-07

Review 10.  Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.